High Tower Advisors, LLC Citius Pharmaceuticals, Inc. Transaction History
High Tower Advisors, LLC
- $68.3 Billion
- Q3 2024
A detailed history of High Tower Advisors, LLC transactions in Citius Pharmaceuticals, Inc. stock. As of the latest transaction made, High Tower Advisors, LLC holds 215,020 shares of CTXR stock, worth $47,304. This represents 0.0% of its overall portfolio holdings.
Number of Shares
215,020
Previous 215,020
-0.0%
Holding current value
$47,304
Previous $124,000
13.71%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CTXR
# of Institutions
59Shares Held
23.4MCall Options Held
83.1KPut Options Held
32.1K-
Armistice Capital, LLC New York, NY7.28MShares$1.6 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.44MShares$1.42 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.88MShares$413,3690.0% of portfolio
-
Black Rock Inc. New York, NY1.81MShares$397,2590.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.16MShares$254,8710.0% of portfolio
About Citius Pharmaceuticals, Inc.
- Ticker CTXR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 146,130,000
- Market Cap $32.1M
- Description
- Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic l...